Page last updated: 2024-11-02

pioglitazone and Brain Disorders

pioglitazone has been researched along with Brain Disorders in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elkahloun, AG1
Rodriguez, Y1
Alaiyed, S1
Wenzel, E1
Saavedra, JM1
Yin, QQ1
Pei, JJ1
Xu, S1
Luo, DZ1
Dong, SQ1
Sun, MH1
You, L1
Sun, ZJ1
Liu, XP1

Other Studies

2 other studies available for pioglitazone and Brain Disorders

ArticleYear
Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARĪ³ Activation.
    Molecular neurobiology, 2019, Volume: 56, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Brain Diseases; Cell Line; Down-Regulati

2019
Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Analysis of Variance; Animals; Brain Diseases; Fructose; Hyperinsulinism; Insulin; Insulin Resistanc

2013